Race Oncology Limited (ASX: RAC)

Race Oncology Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 17, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	218	311	200	311	527	82
Market Cap Growth	55.59%	55.59%	-35.78%	-41.00%	546.75%	1770.25%
Enterprise Value	201	297	173	274	522	80
Last Close Price	1.25	1.82	1.23	1.95	3.67	0.70
PS Ratio	51.57	77.63	63.73	439.48	1360.92	511.48
PB Ratio	11.67	16.97	7.84	8.61	38.42	14.33
P/TBV Ratio	20.05	20.05	8.92	9.50	52.37	46.49
EV/Sales Ratio	50.16	74.21	55.32	387.06	1346.52	501.76
Asset Turnover	0.17	0.17	0.10	0.03	0.04	0.03
Quick Ratio	9.26	9.26	20.16	23.71	18.07	7.30
Current Ratio	9.32	9.32	20.44	24.09	20.24	8.20
Return on Equity (ROE)	-63.10%	-63.10%	-32.22%	-44.96%	-65.32%	-71.62%
Return on Assets (ROA)	-38.63%	-38.63%	-20.41%	-27.05%	-39.39%	-43.96%
Return on Capital (ROIC)	-41.34%	-41.34%	-21.26%	-28.10%	-40.95%	-45.75%
Earnings Yield	-6.69%	-4.45%	-4.97%	-3.60%	-1.20%	-4.72%
FCF Yield	-3.07%	-3.07%	-5.33%	-2.01%	-0.89%	-3.02%
Buyback Yield / Dilution	-2.35%	-2.35%	-4.83%	-17.06%	-22.86%	-33.50%
Total Shareholder Return	-2.35%	-2.35%	-4.83%	-17.06%	-22.86%	-33.50%

Source: S&P Capital IQ. Standard template. Financial Sources.